Life-on-Chip event 2019
Practical information
Many other cross-over innovations are currently at different levels of technological or commercial development. ‘Life-on-Chip – The Road from Idea to Reality’ will bring testimonies of roads travelled and lessons learned by pioneering researchers, entrepreneurs and first application movers.
Through a rich offering of keynote speakers, thematic sessions, prototype and product show cases and matchmaking (B2Match), the event aims to kick-start cross-over partnerships and projects to realize the full potential life-on-chip innovations, accelerating the development of personalized healthcare solutions!
Day 1 - Thursday, February 21st, 2019
Registration/Coffee
Word of welcome
Tom Dehaene, Vice-Governor Internationalisation, Province of Flemish Brabant
Introduction
Jan Schrooten, Co-founder and CEO, Antleron
Keynote: Regenerating the future of healthcare
Prof. Dr. Koen Kas, Healthcare Futurist & Delight Thinker
Keynote: Bridging the gaps between nano, cells and applications
Prof. Dr. Liesbet Lagae, Program Director Life Science Technologies, imec
Reception
Walking dinner
End
Day 2 - Friday, February 22nd, 2019
Registration/Coffee
Welcome & introduction
Jan Schrooten, Co-founder and CEO, Antleron
Keynote 1: The Single Cell Accelerator of VIB
Halina Novak , Technology & Innovation Manager, Flemish Institute for Biotechnology (VIB)
Keynote 2: Bringing 3D-bioprinted blood vessels from the lab to the patient
Prof. Dr. James Kang, CEO en Chief Scientist, Revotek
Keynote 3: Stem cells & technology – reality check from regeneration to disease modelling, drug development and drug screening
Prof. Dr. Catherine Verfaillie , KU Leuven
Coffee break | B2B/One2One
Sessions series 1 | B2B/One2One
Lunch | B2B/One2One
Sessions series 2 | B2B/One2One
Coffee break | B2B/One2One
Financing avenues for ‘Life-on-Chip’ ventures
Bart Motmans, Innovation Manager at EIT Health: ‘Opportunities in EIT Health’ | Marc Van de Craen, Managing Director Biotech Subsidy and PaterGrus: 'Smart Non-Dilutive Funding Strategies are paying off' | Roderick Verhelst, Investment Manager Life Sciences PMV: ‘From research tool to point-of-need molecular diagnostics, a VC’s perspective’
Closing remarks ‘Life-on-Chip’
Willem Dhooge, co-general manager at flanders.bio & Peter Simkens, Cluster Development & Internationalization - Programme Director Nanotechnologies at DSP Valley
Reception
End
Sessions
Sessions Series 1
Lab-on-Chip: lectures and pitches Full
Nicolas Vergauwe (miDIAGNOSTICS), Jan-Willem Hoste (MyCartis), Denis Vandormael (SIRRIS), Filip Legein (VUB)
Session 1 focuses on the commercial maturation of Lab-on-Chip applications, being a class of devices that integrate and automate multiple, molecular biology-based laboratory techniques into a miniaturised and automated system enabling high-throughput screening. Nicolas Vergauwe's lecture: "NanoFluidic Processor: a new tool for near-patient testing"; Denis Vandormael's lecture: "Engineering for Healthcare, a focus on microfluidic chip development", Jan-Willem Hoste's lecture: "Diagnostics where you need it", Filip Legein's pitch: µFlow Cell - Valorization of Microfluidics Research at Free University of Brussels
Merging Cells & Devices: lectures and pitches Full
Jeroen Lammertyn (MiBioS - KU Leuven), Patrik Verstreken (VIB), Elke Giets (MouSensor Europe), Wolfgang Eberle (imec)
Looking ahead into the future, new functionalities can be created through Lab-on-chip by inserting living cells into diagnostics devices. Adding biological functionalities, by crossing a scale of complexity when going from molecular to cellular biology, opens a wide range of applications, but also adds technological development complexity by merging living cell systems with micro devices. Patrik Verstreken's lecture: "Probing Parkinson's disease with Induced Human Microcircuits on CMOS Chips", Elke Giets' lecture: "The Odoromics Chip"
B2B/One2One
Sessions Series 2
Cell-on-Chip Apps: lectures and pitches Full
Adrian Ranga (BIOMAT Interreg), Bart Landuyt (CellSine), Stefan Braam (Ncardia), Thomas Pauwelyn (imec)
Microchips lined with living, human cells can revolutionise drug development, disease modelling and personalised medicine. When biological communication is established with a device at a single-cell or multi-cellular level, specific cell-on-chip applications, become a reality. Adrian Ranga's lecture: "On-chip Bioengineering: Biomaterials x Organoids", Bart Landuyt's lecture: "CellSine, finding the right frequencies to boost drug discovery", Stefan Braam's lecture: "Stem Cell Based Assay Systems for Drug Discovery and Development", Thomas Pauwelyn's pitch: "Cardionostix - Cell-on-chip platform for drug testing and personalised medicine"
Towards Organ-on-Chip and Tissue Manufacturing: lectures and pitches Full
Christian Ramakers (Mimetas), Ute Schepers (VasQLab), Janny van den Eijnden-van Raaij (Institute for Human Organ and Disease Model Technologies), Heidi Declercq (UGent)
Lab-scale cross-over between (re)generation of living cells, advanced 3d-printing technologies for building living cell structures and connecting them to semiconductor structures, opens new horizons towards organ-on-chip. These devices enable novel methodologies for testing the toxicity of new pharmaceuticals on living cells or tissues. In a next step, it will even be possible to generate new, implantable tissue structures and organs. Christian Ramakers' lecture: "Human Tissue Models for Better Therapies", Dr. Janny van den Eijnden-van Raaij's lecture: "ORCHID -Towards a roadmap and community for Organ-on-Chip in Europe", Ute Schepers' lecture: 'Organs-On-A-Chip and Artificial Intelligence Platforms In Personalized Medication Development', Heidi Declercq's pitch: "Hybrid Bioprinting of Complex and Vascularized Tissues'
B2B/One2One
